A potentially deadly parasite that can ulcerate skin, nose, mouth and organs could someday meet its match in an experimental vaccine that has now worked in lab tests on humanized mice.
It's time to develop alternate drugs against small infections as a strategy to slow the antibiotic resistance crisis, Georgia Tech evolutionary bacteriologists say.